Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dengler

Showing results (121-130 of 246) with videos related to

Pageof 25
Sort By:
Heart (British Cardiac Society)|May 16, 2002
Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct sizeM Licka, R Zimmermann, J Zehelein, et al.
Histopathology|May 10, 2006
Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathyE Herpel, M Pritsch, A Koch, et al.
Klinische Wochenschrift|May 15, 1981
Clinical implications of serum digoxin concentrationsH R Ochs, D J Greenblatt, J S Harmatz, et al.
Transplantation Proceedings|June 1, 1995
Impaired renal function but not high cyclosporine levels determines increased endothelin plasma levels after heart transplantationT J Dengler, C P Tiefenbacher, K Braun, et al.
Transplantation Proceedings|May 22, 1998
Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantationT J Dengler, G Szabo, K Amann, et al.
Transplantation Proceedings|September 25, 2002
Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantationC A Gleissner, J Zehelein, F U Sack, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 14, 1998
Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejectionS Bährle, G Szabó, A Stiehl, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 14, 2005
Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat)Achim Koch, Volker Daniel, Thomas J Dengler, et al.
Clinical Therapeutics|July 25, 2006
A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimensAndreas O Dösch, Philipp Ehlermann, Achim Koch, et al.
Vaccine|March 6, 1999
Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipientsT J Dengler, R Zimmermann, J Meyer, et al.
Pageof 25

Showing results (121-130 of 246) with videos related to

Sort By:
Pageof 25
Heart (British Cardiac Society)|May 16, 2002
Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct sizeM Licka, R Zimmermann, J Zehelein, et al.
Histopathology|May 10, 2006
Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathyE Herpel, M Pritsch, A Koch, et al.
Klinische Wochenschrift|May 15, 1981
Clinical implications of serum digoxin concentrationsH R Ochs, D J Greenblatt, J S Harmatz, et al.
Transplantation Proceedings|June 1, 1995
Impaired renal function but not high cyclosporine levels determines increased endothelin plasma levels after heart transplantationT J Dengler, C P Tiefenbacher, K Braun, et al.
Transplantation Proceedings|May 22, 1998
Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantationT J Dengler, G Szabo, K Amann, et al.
Transplantation Proceedings|September 25, 2002
Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantationC A Gleissner, J Zehelein, F U Sack, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 14, 1998
Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejectionS Bährle, G Szabó, A Stiehl, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 14, 2005
Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat)Achim Koch, Volker Daniel, Thomas J Dengler, et al.
Clinical Therapeutics|July 25, 2006
A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimensAndreas O Dösch, Philipp Ehlermann, Achim Koch, et al.
Vaccine|March 6, 1999
Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipientsT J Dengler, R Zimmermann, J Meyer, et al.
Pageof 25